Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California

项目2VIDA！

• 批准号: 10733348
• 负责人: Argentina Elisa Noelle Servin
• 金额: $ 12.5万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-23 至 2023-08-01
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10733348
• 关键词: Address; Adult; Affect; African American; Attitude; Black Populations; Black race; COVID-19; COVID-19 severity; COVID-19 vaccination; COVID-19 vaccine; California; Caring; Chronic; Communities; Data Analyses; Diabetes Mellitus; Focus Groups; Future; Health; Heart Diseases; High Prevalence; Hypertension; Individual; Influenza vaccination; Institution; Intervention; Latinx; Latinx population; Link; Lung diseases; Measures; Mediating; Mediation; Medical; Mentorship; Methods; Not Hispanic or Latino; Outcome; Participant; Perception; Persons; Population; Public Health; Race; Recommendation; Research; Research Personnel; SARS-CoV-2 negative; Services; Surveys; Training; Trust; Vaccination; Vaccines; Work; disadvantaged background; distrust; diversity and inclusion; experience; health disparity; high risk; intervention delivery; maltreatment; marginalized community; marginalized population; pandemic disease; physical conditioning; racial population; racism; response; service delivery; trustworthiness; vaccination outcome; vaccine acceptance; vaccine delivery; vaccine hesitancy

PROJECT SUMMARY COVID-19 has disproportionately impacted marginalized people, particularly those from Black and Latinx communities. Prior to the pandemic, Black and Latinx populations already had higher rates of chronic conditions such as hypertension, lung disease, heart disease, and diabetes, which have placed them at much higher risk for negative COVID-19 outcomes compared to non-Hispanic white populations. While COVID-19 vaccination has been identified as an important public health measure for addressing the spread and severity of COVID-19, vaccine hesitancy remains a significant issue. Previous research has linked COVID-19 vaccine hesitancy among Black and Latinx communities to historical and contemporary experiences of medical racism; however, the high prevalence of chronic conditions among Black and Latinx communities complicates questions around trust and vaccine hesitancy. For instance, while some research has found that individuals with chronic conditions were less hesitant to accept COVID-19 vaccination than individuals without chronic conditions, other work has suggested that racialized individuals with chronic conditions remained vaccine hesitant. Previous research on flu vaccination has also found an association between vaccine hesitancy and previous experiences of medical mistreatment among individuals with chronic health conditions. There is some evidence to suggest that racialized individuals with chronic conditions are less likely to seek medical care due to experiences of medical racism which have increased distrust, which may be one factor contributing to vaccine hesitancy. While a large body of research has examined vaccine attitudes among racialized populations and people with chronic conditions, there has been less research examining actual COVID-19 vaccine outcomes for these populations. Additionally, there has been a substantial amount of research calling for methods that can increase marginalized communities’ trust in vaccination through community-based partnerships and delivery of vaccine information by trusted entities. Project 2VIDA! uses a community-engaged approach to vaccine promotion and provides a valuable opportunity to examine vaccine outcomes for racialized individuals with chronic conditions. The proposed project will seek to better understand the relationship between chronic physical health conditions, institutional trust, and vaccine outcomes among 2VIDA! participants using community-based, mixed-methods approaches. This analysis will provide additional context for vaccine uptake and attitudes among participants as well as expanding the CBPR approach to explore possibilities for applying findings from Project 2VIDA! to future community-led interventions. This project will also allow the training of a junior researcher who comes from a disadvantaged background and is committed to addressing health disparities as well as advancing diversity and inclusion in research through mentorship and academic service.

项目摘要 COVID-19对边缘化人群造成了不成比例的影响，特别是黑人 拉丁裔社区在大流行之前，黑人和拉丁裔人口的 高血压、肺病、心脏病和糖尿病等慢性病的发病率， 这使他们面临更高的COVID-19负面结果的风险， 非西班牙裔白色人群。虽然COVID-19疫苗接种已被确定为 疫苗是应对COVID-19传播和严重程度的重要公共卫生措施， 犹豫不决仍然是一个重要问题。先前的研究已将COVID-19疫苗 黑人和拉丁裔社区对历史和当代经验的犹豫， 医疗种族主义;然而，黑人和拉丁裔慢性病的高患病率 社区使信任和疫苗犹豫问题复杂化。例如，虽然 一些研究发现，患有慢性病的人更愿意接受 其他研究表明，COVID-19疫苗接种比没有慢性病的个人更有效 种族化的慢性病患者仍然对疫苗犹豫不决。以前的研究 关于流感疫苗接种的研究还发现， 慢性病患者遭受医疗虐待的经历。有 一些证据表明，患有慢性病的种族化个体不太可能 由于医疗种族主义的经历而寻求医疗保健，这增加了不信任， 可能是导致疫苗犹豫的一个因素。虽然大量的研究表明， 研究了种族化人群和慢性病患者对疫苗的态度， 对这些人的实际COVID-19疫苗结果的研究较少， 人口。此外，有大量的研究呼吁方法， 这可以通过基于社区的疫苗接种增加边缘化社区对疫苗接种的信任， 伙伴关系和由可信实体提供疫苗信息。2 VIDA计划！使用 社区参与的疫苗推广方法，并提供了宝贵的机会， 检查慢性疾病种族化个体的疫苗结果。拟议 项目将寻求更好地了解慢性身体健康之间的关系， 条件，机构信任和疫苗的结果之间2 VIDA！参与者使用 以社区为基础的混合方法。这一分析将提供更多的背景， 疫苗的使用和参与者的态度，以及扩大CBPR方法， 探索应用2 VIDA项目发现的可能性！到未来的社区主导 干预措施。该项目还将培训一名初级研究员， 弱势背景，并致力于解决健康差距，以及 通过导师制和学术服务推进研究的多样性和包容性。